BB BIOTECH NAM. SF 0,20/ CH0038389992 /
| 2024-12-20 7:18:30 PM | Chg. +0.3000 | Volume | Bid8:08:02 PM | Ask7:18:30 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 37.8000EUR | +0.80% | 6,416 Turnover: 238,870.1500 |
-Bid Size: - | -Ask Size: - | 2.11 bill.EUR | - | - |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | -3.77 CHF | -42.00% |
| EPS Diluted: | - CHF | -42.00% |
| Revenues per Share: | 0.01 CHF | -57.94% |
| Book Value per Share: | 41.94 CHF | -13.51% |
| Cash Flow per Share: | 3.94 CHF | -5.56% |
| Dividend per Share: | 2.00 CHF | -29.82% |
| Total | in mill. | |
| Revenues: | 0.53 CHF | -57.94% |
| Net Income: | -206.61 CHF | -42.26% |
| Operating Cash Flow: | 218.28 CHF | - |
| Cash and Cash Equivalents: | 0.50 CHF | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | - | - |
| P/S Ratio: | 3,700.30 | 4,468.58 |
| P/BV ratio: | 0.84 | 1.02 |
| P/CF Ratio: | 8.98 | 10.85 |
| PEG: | 0.22 | - |
| Earnings Yield: | -10.65% | -8.82% |
| Dividend Yield: | 5.65% | 4.68% |
| Market Capitalization | ||
| Market Capitalization: | 2.11 bill. EUR | 2.55 bill. EUR |
| Free Float Market Cap.: | - EUR | - EUR |
| Market Cap. / Employee: | 22.4 mill. EUR | 27.13 mill. EUR |
| Shares Outstanding: | 54.84 mill. | |
Profitability
| Gross Profit Margin: | - |
| EBIT Margin: | 0.00% |
| Net Profit Margin: | -38,982.45% |
| Return on Equity: | -8.89% |
| Return on Assets: | -7.83% |
Financial Strength
| Liquidity I / Cash Ratio: | - |
| Liquidity II / Quick Ratio: | - |
| Liquidity III / Current Ratio: | - |
| Debt / Equity Ratio: | 13.51% |
| Dynam. Debt / Equity Ratio: | 143.83% |
Efficiency
| Employees: | 94 |
| Personal Expenses / Employee: | - CHF |
| Revenues / Employee: | 5,638.30 CHF |
| Net Income / Employee: | -2,197,946.81 CHF |
| Total Assets / Employee: | 28,054,829.79 CHF |
| * Fiscal Year End: | 2023-12-31 |
| Accounting Standard: | IFRS |
| Currency: | CHF |
